Genomic and Precision Medicine (3rd Ed.) Primary Care
Coordonnateurs : Ginsburg Geoffrey S., Willard Huntington F, David Sean P.
Genomic and Precision Medicine: Primary Care, Third Edition is an invaluable resource on the state-of-the-art tools, technologies and policy issues that are required to fully realize personalized health care in the area of primary care.
One of the major areas where genomic and personalized medicine is most active is the realm of the primary care practitioner. Risk, family history, personal genomics and pharmacogenomics are becoming increasingly important to the PCP and their patients, and this book discusses the implications as they relate to primary care practitioners.
1. Genomic Medicine in Primary Care 2. Overview of Policy, Ethical, and Social Considerations in Genomic and Personalized Medicine 3. Educational Issues and Strategies for Genomic Medicine 4. Genetic Testing for Rare and Undiagnosed Diseases 5. Health Risk Assessments, Family Health History, and Predictive Genetic/Pharmacogenetic Testing 6. Pharmacogenetics and Pharmacogenomics 7. Hypertension 8. Coronary Artery Disease and Myocardial Infarction 9. Lung Cancer 10. Breast Cancer 11. Colorectal Cancer 12. Prostate Cancer 13. Asthma 14. Diabetes 15. Metabolic Syndrome 16. Autism Spectrum Disorder 17. Viral Hepatitis
Huntington Willard is on the faculty of the Department of Human Genetics at the University of Chicago. Prior to this appointment, Willard was the President and Director of the Marine Biological Laboratory and Professor of Human Genetics at the University of Chicago. He was previously on the faculty at Duke University, where he was founding director of the university-wide Duke Institute for Genome Sciences & Policy from 2003 to 2014, the Nanaline H. Duke Professor of Genome Sciences, and the Arts & Sciences Professor of Biology & Genome Sciences.
Dr. David is a family doctor and physician scientist interested in translational research to improve preventive health and public health strategies to improve population health.
- Presents a comprehensive volume for primary care providers
- Provides succinct commentary and key learning points that will assist providers with their local needs for the implementation of genomic and personalized medicine
- Includes a current overview on major opportunities for genomic and personalized medicine in practice
- Highlights case studies that illustrate the practical use of genomics in the management in patients
Date de parution : 03-2017
Ouvrage de 370 p.
15x22.8 cm
Thème de Genomic and Precision Medicine :
Mots-clés :
APC; Acute infection; Adverse drug reactions; Airway biomarker; Asthma; Asthma genetics; Atherosclerosis; Autism spectrum disorder; Basal-like; Beta cell; Blood pressure; Breast cancer; CRC syndromes; CYP2C19; CYP2D6; Candidate gene; Cardio-MetaboChip; Cell-free DNA; Chemoprevention; Chronic infection; Cirrhosis; Colorectal cancer; Competency; Coronary artery disease; DNA; DNA methylation; Decipher; Diabetes; Diagnosis; Dyslipidemia; Education; Estrogen receptor; Ethics; Evidence-based guidelines; Exome chip; Exome sequencing; Familial implications; Family health history; Fibrosis; Field cancerization; Gene expression profiling; Genetic risk scores; Genetic testing; Genetic-risk score; Genetics; Gene-environment interactions; Gene-gene interactions; Genome-wide association; Genome-wide association studies; Genome-wide association study; Genomic medicine; Genomic revolution; Genomics; Genotype; Germline genetics; Glucose; HER-2 receptor; HLA-B5701; Health risk assessment; Hepatitis; Hepatitis B; Hepatitis C; Heritability; Hypertension; Individualized therapy; Insulin; Insulin resistance; Intrinsic breast cancer subtypes; Lipodystrophy; Liver; Liver cancer; Luminal; Lung cancer genomics; MUTYH; Mammaprint (all with â„¢); Mendelian; Mendelian randomization; Metaanalysis; Metabolic syndrome; Molecular-based classifications; Molecularly targeted therapy; Myocardial infarction; NTHL1; Neurodevelopmental disorders; Next-generation sequencing; Nurse practitioner; Obesity; Oncogenic pathway signatures; Oncotype Dx; Oversight; Pathway-based pharmacogenomics; Personalized medicine; Pharmacogenetics; Pharmacogenomics; Phenotype; Physician; Physician assistant; Pleiotropy; Polyposis; Prediction